TrueShares Structured Outcome (March) ETF
MARZ · ETF
About MARZ
- Issuer
- TrueShares
- Expense ratio
- 0.79%
- Assets under management
- $33.79M
- Inception
- Feb 26, 2021
- Asset class
- Alternatives
- Website
- truesharesetfs.com
MARZ key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 1.84K
- Volume
- 36
- Open price
- $37.18
- High today
- $37.02
- Low today
- $37.02
- 52 Week high
- $37.87
- 52 Week low
- $32.27
TrueShares Structured Outcome (March) ETF (MARZ) at a glance
As of Oct 23, 2026, TrueShares Structured Outcome (March) ETF (MARZ) shares are priced at $37.02, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.
Volume so far is 36 shares, below the average of 1.84K shares a day.
Over the past year TrueShares Structured Outcome (March) ETF has ranged from $32.27 to $37.87, and now sits 85% of the way up that range.
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.